Literature DB >> 20735278

Application of breast MRI for prediction of lymph node metastases - systematic approach using 17 individual descriptors and a dedicated decision tree.

Matthias Dietzel1, Pascal A T Baltzer, Tibor Vag, Tobias Gröschel, Mieczyslaw Gajda, Oumar Camara, Werner A Kaiser.   

Abstract

BACKGROUND: The presence of lymph node metastases (LNMs) is one of the most important prognostic factors in breast cancer.
PURPOSE: To correlate a detailed catalog of 17 descriptors in breast MRI (bMRI) with the presence of LNMs and to identify useful combinations of such descriptors for the prediction of LNMs using a dedicated decision tree.
MATERIAL AND METHODS: A standardized protocol and study design was applied in this IRB-approved study (T1-weighted FLASH; 0.1 mmol/kg body weight Gd-DTPA; T2-weighted TSE; histological verification after bMRI). Two experienced radiologists performed prospective evaluation of the previously acquired examination in consensus. In every lesion 17 previously published descriptors were assessed. Subgroups of primary breast cancers with (N+: 97) and without LNM were created (N-: 253). The prevalence and diagnostic accuracy of each descriptor were correlated with the presence of LNM (chi-square test; diagnostic odds ratio/DOR). To identify useful combinations of descriptors for the prediction of LNM a chi-squared automatic interaction detection (CHAID) decision tree was applied.
RESULTS: Seven of 17 descriptors were significantly associated with LNMs. The most accurate were "Skin thickening" (P < 0.001; DOR 5.9) and "Internal enhancement" (P < 0.001; DOR <or=13.7). The CHAID decision tree identified useful combinations of descriptors: "Skin thickening" plus "Destruction of nipple line" raised the probability of N+ by 40% (P< 0.05). In case of absence of "Skin thickening", "Edema", and "Irregular margins", the likelihood of N+ was 0% (P<0.05).
CONCLUSION: Our data demonstrate the close association of selected breast MRI descriptors with nodal status. If present, such descriptors can be used - as stand alone or in combination - to accurately predict LNM and to stratify the patient's prognosis.

Entities:  

Mesh:

Year:  2010        PMID: 20735278     DOI: 10.3109/02841851.2010.504232

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  13 in total

1.  A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography.

Authors:  Pascal A T Baltzer; Matthias Dietzel; Werner A Kaiser
Journal:  Eur Radiol       Date:  2013-04-12       Impact factor: 5.315

2.  What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?

Authors:  Diomidis Botsikas; Ilias Bagetakos; Marlise Picarra; Ana Carolina Da Cunha Afonso Barisits; Sana Boudabbous; Xavier Montet; Giang Thanh Lam; Ismini Mainta; Anastasia Kalovidouri; Minerva Becker
Journal:  Eur Radiol       Date:  2018-09-28       Impact factor: 5.315

3.  Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade.

Authors:  Ioannis Stasinopoulos; Marie-France Penet; Balaji Krishnamachary; Zaver M Bhujwalla
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 4.  Clinical role of breast MRI now and going forward.

Authors:  D Leithner; G J Wengert; T H Helbich; S Thakur; R E Ochoa-Albiztegui; E A Morris; K Pinker
Journal:  Clin Radiol       Date:  2017-12-09       Impact factor: 2.350

Review 5.  MRI of metastasis-permissive microenvironments.

Authors:  Marie-France Penet; Zhihang Chen; Zaver M Bhujwalla
Journal:  Future Oncol       Date:  2011-11       Impact factor: 3.404

Review 6.  'Omic approaches to preventing or managing metastatic breast cancer.

Authors:  Obi L Griffith; Joe W Gray
Journal:  Breast Cancer Res       Date:  2011-12-08       Impact factor: 6.466

7.  Epithelial-mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer.

Authors:  X-J Fan; X-B Wan; Y Huang; H-M Cai; X-H Fu; Z-L Yang; D-K Chen; S-X Song; P-H Wu; Q Liu; L Wang; J-P Wang
Journal:  Br J Cancer       Date:  2012-04-26       Impact factor: 7.640

8.  Sequential [18F]FDG-[18F]FMISO PET and Multiparametric MRI at 3T for Insights into Breast Cancer Heterogeneity and Correlation with Patient Outcomes: First Clinical Experience.

Authors:  Piotr Andrzejewski; Georg Wengert; Thomas H Helbich; Heinrich Magometschnigg; Dietmar Georg; Marcus Hacker; Pascal Baltzer; Paola Clauser; Panagiotis Kapetas; Petra Georg; Wolfgang Wadsak; Katja Pinker
Journal:  Contrast Media Mol Imaging       Date:  2019-01-08       Impact factor: 3.161

9.  DW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts.

Authors:  Tord Hompland; Christine Ellingsen; Kanthi Galappathi; Einar K Rofstad
Journal:  BMC Cancer       Date:  2014-02-15       Impact factor: 4.430

Review 10.  How to use the Kaiser score as a clinical decision rule for diagnosis in multiparametric breast MRI: a pictorial essay.

Authors:  Matthias Dietzel; Pascal A T Baltzer
Journal:  Insights Imaging       Date:  2018-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.